Warning: This security is no longer trading.
defunct
Proteostasis Therapeutics, Inc. (PTI): Price and Financial Metrics
PTI Price/Volume Stats
| Current price | $1.11 | 52-week high | $2.72 |
| Prev. close | $1.15 | 52-week low | $0.87 |
| Day low | $1.10 | Volume | 2,110,100 |
| Day high | $1.20 | Avg. volume | 1,036,509 |
| 50-day MA | $1.10 | Dividend yield | N/A |
| 200-day MA | $1.30 | Market Cap | 57.93M |
PTI Stock Price Chart Interactive Chart >
Proteostasis Therapeutics, Inc. (PTI) Company Bio
Proteostasis Therapeutics, Inc., a biopharmaceutical company, develops therapeutics to treat protein conformational diseases. The company offers disease-modifying therapeutics for cystic fibrosis; and also develops treatments for diseases caused by an imbalance in the proteostasis network and characterized by defects in protein folding, trafficking, and clearance, including genetic, neurodegenerative, and retinal degenerative diseases. The company was founded in 2006 and is based in Cambridge, Massachusetts.
PTI Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -36.57% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -29.63% |
Continue Researching PTI
Want to see what other sources are saying about Proteostasis Therapeutics Inc's financials and stock price? Try the links below:Proteostasis Therapeutics Inc (PTI) Stock Price | Nasdaq
Proteostasis Therapeutics Inc (PTI) Stock Quote, History and News - Yahoo Finance
Proteostasis Therapeutics Inc (PTI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...